« Back
Home /
Obatoclax Mesylate

Obatoclax Mesylate

€54.00

Excl. VAT

Item no.	HY-10969-5mg
Manufacturer	MedChem Express
CASRN	803712-79-0
Amount	5 mg
Category	Oncology Inhibitors & Compound Libraries Small Molecules By Organ Colorectal Cancer Heart & Blood Cancer Thyroid Cancer
Type	Inhibitors
Clone	N/A
Specific against	other
Purity	99.74
Formula	C21H23N3O4S
Citations	Am J Cancer Res. 2019 Mar 1;9(3):546-561. Biomed Pharmacother. 2020 Sep;129:110371. Cancer Lett. 2022 Nov 30;216028. iScience. 13 August 2022, 104925. Norwegian University of Science and Technology. Department of Clinical and Molecular Medicine. 2021 Oct. Sci Rep. 2019 Sep 24;9(1):13786. Viruses. 2020 Oct 18;12(10):1178. ACS Infect Dis. 2023 Oct 5. Acta Pharmacol Sin. 2021 Aug;42(8):1298-1310. Departamento de Biotecnología - Departament de Biotecnologia. 2020 Sep 7. [1]Sulkshane P, et al. BH3 mimetic Obatoclax (GX15-070) mediates mitochondrial stress predominantly via MCL-1 inhibition and induces autophagy-dependent necroptosis in human oral cancer cells. Oncotarget. 2016 Aug 5;8(36):60060-60079. [2]Ehrenkaufer G, et al. Identification of anisomycin, prodigiosin and obatoclax as compounds with broad-spectrum anti-parasitic activity. PLoS Negl Trop Dis. 2020 Mar 20;14(3):e0008150. [3]Or CR, et al. Obatoclax, a Pan-BCL-2 Inhibitor, Targets Cyclin D1 for Degradation to Induce Antiproliferation in Human Colorectal Carcinoma Cells. Int J Mol Sci. 2016 Dec 27;18(1). [4]Nguyen M, et al. Small molecule obatoclax (GX15-070) antagonizes MCL-1 and overcomes MCL-1-mediated resistance to apoptosis. Proc Natl Acad Sci U S A. 2007 Dec 4;104(49):19512-7. Epub 2007 Nov 26.
Smiles	COC1=CC(C2=CC3=C(C=CC=C3)N2)=N/C1=C\C4=C(C=C(N4)C)C.CS(=O)(O)=O
ECLASS 10.1	32160490
ECLASS 11.0	32160490
UNSPSC	12000000
Alias	GX15-070 (Mesylate)
Available
Product Description	Obatoclax Mesylate (GX15-070 Mesylate), a BH3 mimetic, is a pan-BCL-2 family proteins inhibitor with a Ki of 220 nM for BCL-2[1][2]. Obatoclax Mesylate induces autophagy-dependent cell death and targets cyclin D1 for proteasomal degradation. Obatoclax Mesylate has anti-cancer and broad-spectrum antiparasitic activity[3][4].
StorageTemperature	4°C (Powder, sealed storage, away from moisture and light)
Shipping	Room Temperature
Manufacturers Applications	Cancer-Kinase/protease
Molecular Weight	413.49
Clinical Information	Phase 3
Solubility	DMSO : 12.5 mg/mL (ultrasonic)
Isoform	Bcl-2; Bcl-B; Bcl-W; Bcl-xL; Mcl-1
Pathway	Anti-infection; Apoptosis; Autophagy
Manufacturers Product type	Reference compound

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

HY-10969-5mg-safety-datasheet.pdf